NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.65
-0.30 (-0.83%)
Dec 24, 2025, 1:00 PM EST - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $4.04 billion as of December 24, 2025. Its market cap has increased by 136.26% in one year.
Market Cap
4.04B
Enterprise Value
3.29B
1-Year Change
136.26%
Ranking
Category
Stock Price
$35.65
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $4.04B, an increase of 2,517.29%. That is a compound annual growth rate of 95.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 4.04B | 46.93% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | 154.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.86B |
| Johnson & Johnson | 499.50B |
| AbbVie | 402.80B |
| UnitedHealth Group | 294.54B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.92B |
| Abbott Laboratories | 217.70B |